跳至主要内容
临床试验/ACTRN12610000090011
ACTRN12610000090011尚未招募未知

utrigenomic risk profiles for Mild Cognitive Impairment, Alzheimer's disease and Parkinson's disease

Commonwealth Scientific and Industrial Research Organisation0 个研究点目标入组 900 人开始时间: 2010年1月27日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
900

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
55 Years 至 100 Years(—)
性别
All

入选标准

  • Control Group:
  • Male or female, Aged 55 and above, Not clinically diagnosed with mild cognitive impairment, Alzheimer's disease and Parkinson's, No family history of mild cognitive impairment, Alzheimer's disease and Parkinson's disease
  • Mild cognitive impairment Group:
  • Male or female, Aged 55 and above, Clinically diagnosed with mild cognitive impairment
  • Alzheimer's disease Group:
  • Male or female, Aged 55 and above, Clinically diagnosed with Alzheimer's disease
  • Parkinson's disease Group:
  • Male or female, Aged 55 or above, Clinically diagnosed with Parkinson's disease

排除标准

  • Control Group:
  • Patients who are undergoing chemotherapy,radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance
  • Mild cognitive impairment Group:
  • Patients who are undergoing chemotherapy, radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance
  • Alzheimer's disease Group:
  • Patients who are undergoing chemotherapy, radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance
  • Parkinson's disease Group:
  • Patients who are undergoing chemotherapy, radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance

研究者

相似试验

utrigenomic risk profiles for Mild Cognitive... | 临床试验